查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967641

眼科PACS市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、運作模式、最終用途、地區和競爭格局分類，2021-2031年

Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Mode of Action, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球眼科 PACS 市場預計將從 2025 年的 1.4164 億美元成長到 2031 年的 2.1078 億美元，複合年成長率為 6.85%。

眼科影像存檔和通訊系統（OPCS）是專門開發的數位平台，用於在統一的介面中擷取、儲存、搜尋和管理眼科診斷影像，例如眼底照片和光學同調斷層掃描。這個市場的主要促進因素包括：高患者量診所迫切需要簡化工作流程，以及全球眼科疾病盛行率不斷上升，這需要強大的資料管理基礎設施。正如國際防盲協會在2025年指出的那樣，預計到2050年，全球視力喪失人口將達到18億，這凸顯了對可擴展診斷成像解決方案的迫切需求。

市場概覽
預測期 2027-2031
市場規模：2025年 1.4164億美元
市場規模：2031年 210,780,000 美元
複合年成長率：2026-2031年 6.85%
成長最快的細分市場 整合PACS
最大的市場 北美洲

市場成長的一大障礙是傳統眼科設備之間互通性不足這一持續存在的挑戰。這些設備通常採用專有資料格式，而非通用的DICOM標準。這種技術碎片化使得各種成像設備難以與中央資料庫和電子健康記錄整合，從而增加了實施成本。這些問題導致數據孤島，阻礙了全面的患者照護，並給致力於維持高效協調的診斷環境的醫療機構帶來了挑戰。

市場促進因素

眼科疾病和視力障礙的日益普遍是推動眼科影像歸檔和通訊系統（PACS）普及應用的主要動力。醫療機構正努力應對快速成長的診斷數據，隨著人口老化和糖尿病等慢性病的日益增多，診所亟需強大的數位化歸檔系統，以便高效儲存和搜尋長期影像記錄，從而實現有效的疾病監測。需要定期篩檢的人群規模龐大，更凸顯了這項需求。根據美國疾病管制與預防中心（CDC）2024年5月發布的《速覽：視力喪失》報告，光是美國就有約9,300萬成年人面臨嚴重視力喪失的高風險，這需要可擴展的基礎設施來處理相關的診斷工作量。

同時，人工智慧 (AI) 的整合應用正在推動市場變革，增強影像分析能力，使 PACS（影像存檔和通訊系統）從單純的儲存庫轉變為主動式診斷支援中心。現代平台擴大整合 AI 演算法，用於自動檢測糖尿病視網膜病變等病變，從而減少人工評估時間和錯誤。 HCPLive 發布的《2024 年眼科年度回顧》（2024 年 12 月）報告了一項重大進展：美國 FDA核准了首款全自動、AI 驅動的攜帶式糖尿病視網膜病變篩檢設備。 Topcon Healthcare 與微軟於 2024 年建立策略合作夥伴關係，共同開發 AI 驅動的雲端連結眼科健康解決方案，進一步推動了這項向智慧醫療的轉變。

市場挑戰

全球眼科PACS市場擴張的一大障礙是傳統眼科設備之間持續存在的互通性不足問題。由於許多診斷設備採用專有資料格式而非普遍接受的DICOM標準，醫療機構面臨嚴重的技術碎片化問題。這種碎片化環境阻礙了影像資料無縫傳輸至中央儲存庫，導致資料孤島的形成，並擾亂了臨床工作流程。無法輕鬆地跨系統聚合和存取影像顯著降低了PACS解決方案的營運價值，使得醫療機構不願投資或升級這些平台。

這種技術上的不相容性直接阻礙了市場推廣，增加了實施成本和管理負擔，因為醫療機構更傾向於能夠輕鬆整合到現有基礎設施中的解決方案。對連接性的需求非常高；根據美國醫學會 (AMA) 2024 年的一項調查，84% 的醫生認為有效的電子健康記錄 (EHR) 整合是採用新型數位醫療技術的先決條件。目前缺乏強大的互通性導致眼科診所不願擴展其數位成像能力，從而延緩了整體市場收入潛力和地域覆蓋範圍的擴大。

市場趨勢

向基於雲端和SaaS的部署模式的轉變正在革新全球眼科PACS市場，使其能夠突破診所的物理限制，實現可擴展的資料集中化。隨著醫療服務提供者整合來自多個地點的診斷影像數據，雲端架構能夠柔軟性管理大量資料集，而無需大規模的本地IT投資。這一趨勢在高頻篩檢平台的部署中尤其明顯。根據拓普康醫療（Topcon Healthcare）2025年7月發布的新聞稿《拓普康醫療收購智慧視網膜成像系統》（Topcon Healthcare Acquisitions Intelligent Retinal Imaging Systems），該公司雲端基礎視網膜篩檢技術已完成超過180萬次檢查，並識別出超過27.9萬個糖尿病病變，這充分展現了研究能力。

同時，遠距眼科和遠距醫療能力的擴展正在改變患者管理策略，尤其是在慢性病監測方面。為了最佳化專家資源，診所正在驗證混合醫療模式，即遠端進行影像檢查，並透過PACS系統非同步解讀。這些工作流程已被證明是傳統評估方法的可靠替代方案。例如，2025年4月在美國眼科學會（ARVO）上發表的一篇題為「混合遠端醫療模式在青光眼管理中的有效性」的摘要顯示，約95%的混合遠端醫療會診得出的觀察和治療方案與面對面會診的結果和方案一致。這凸顯了推動遠距離診斷服務普及的可靠性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球眼科PACS市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（獨立PACS、整合式PACS）
    • 依運作模式（本機部署系統、雲端系統）
    • 依最終用戶（醫院、專科診所等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美眼科PACS市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲眼科PACS市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區眼科PACS市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲眼科PACS市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲眼科PACS市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球眼科PACS市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Carl Zeiss Meditec AG
  • Topcon Corp
  • Heidelberg Engineering GmbH
  • Sonomed Escalon
  • Visbion Ltd
  • Eyepacs LLC
  • VersaSuite
  • Merge Healthcare Inc
  • ScImage Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 21824

The Global Ophthalmology PACS Market is projected to expand from USD 141.64 Million in 2025 to USD 210.78 Million by 2031, reflecting a compound annual growth rate of 6.85%. Ophthalmology Picture Archiving and Communication Systems are specialized digital platforms developed to acquire, store, retrieve, and manage ophthalmic diagnostic images, such as fundus photographs and optical coherence tomography scans, within a unified interface. The primary factors driving this market include the urgent need for improved workflow efficiency in high-volume clinics and the increasing global prevalence of eye diseases, which demands robust data management infrastructures. As noted by the International Agency for the Prevention of Blindness in 2025, the number of individuals globally affected by vision loss is expected to reach 1.8 billion by 2050, highlighting a critical need for scalable imaging solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 141.64 MIllion
Market Size 2031USD 210.78 MIllion
CAGR 2026-20316.85%
Fastest Growing Segmentintegrated PACS
Largest MarketNorth America

A significant barrier to market growth is the ongoing challenge of limited interoperability among legacy ophthalmic devices, which often rely on proprietary data formats instead of the universal DICOM standard. This technical fragmentation makes it difficult to integrate various imaging modalities with central repositories and Electronic Medical Records, leading to increased implementation costs. Consequently, these issues create data silos that obstruct comprehensive patient care, posing a challenge for healthcare providers attempting to maintain efficient and connected diagnostic environments.

Market Driver

The increasing prevalence of ophthalmic disorders and vision impairment serves as a major catalyst for the adoption of Ophthalmology PACS, as healthcare providers struggle to manage rapidly growing volumes of diagnostic data. With aging populations and the rise of chronic conditions like diabetes, clinics require robust digital archiving systems to efficiently store and retrieve longitudinal imaging records for effective disease monitoring. This demand is highlighted by the scale of the population requiring regular screening; according to the Centers for Disease Control and Prevention's 'Fast Facts: Vision Loss' report from May 2024, approximately 93 million adults in the United States alone are at high risk for serious vision loss, necessitating scalable infrastructure to handle the associated diagnostic workload.

Concurrently, the integration of Artificial Intelligence for enhanced image analysis is driving market evolution by transforming PACS from simple storage repositories into active diagnostic support hubs. Modern platforms are increasingly embedding AI algorithms to automatically detect pathologies such as diabetic retinopathy, thereby reducing manual grading time and errors. A significant advancement was noted by HCPLive in 'Ophthalmology Year in Review: 2024' (December 2024), reporting that the U.S. FDA cleared the first fully autonomous AI for portable diabetic retinopathy screening. This shift toward intelligent care is further evidenced by Topcon Healthcare's 2024 strategic partnership with Microsoft to develop AI-powered, cloud-connected ocular health solutions.

Market Challenge

A substantial barrier to the expansion of the Global Ophthalmology PACS Market is the persistent issue of limited interoperability among legacy ophthalmic devices. Since many diagnostic instruments utilize proprietary data formats rather than the universal DICOM standard, healthcare providers encounter severe technical fragmentation. This disjointed ecosystem prevents the seamless transfer of imaging data into centralized repositories, resulting in isolated data silos that disrupt clinical workflows. When images cannot be easily aggregated or accessed across different systems, the operational value of a PACS solution is significantly reduced, discouraging healthcare facilities from investing in or upgrading these platforms.

This technical incompatibility directly stifles market adoption by inflating implementation costs and administrative burdens, as healthcare organizations prefer solutions that integrate effortlessly with existing infrastructures. The demand for connectivity is substantial; according to the American Medical Association in 2024, 84% of physicians identified effective Electronic Health Record integration as a mandatory requirement for adopting new digital health technologies. Without robust interoperability, ophthalmology clinics remain hesitant to scale their digital imaging capabilities, thereby slowing the market's overall revenue potential and geographic reach.

Market Trends

The shift toward Cloud-Based and SaaS Deployment Models is revolutionizing the Global Ophthalmology PACS Market by facilitating scalable data centralization beyond the physical confines of clinics. As healthcare providers integrate diagnostic imaging from various locations, cloud architectures offer the flexibility required to manage massive datasets without significant on-premise IT investments. This trend is particularly visible in the adoption of platforms built for high-volume screening. According to a July 2025 press release from Topcon Healthcare titled 'Topcon Healthcare Acquires Intelligent Retinal Imaging Systems,' their cloud-based retinal screening technology has enabled over 1.8 million screenings and identified more than 279,000 cases of diabetic pathology, proving the capacity of cloud solutions to support large-scale diagnostic networks.

Simultaneously, the expansion of Tele-ophthalmology and Remote Care Capabilities is altering patient management strategies, especially for monitoring chronic conditions. Driven by the need to optimize specialist availability, clinics are increasingly validating hybrid care models where imaging is performed remotely and reviewed asynchronously via PACS integration. These workflows are proving to be clinically reliable alternatives to traditional assessments. For instance, an April 2025 abstract from the Association for Research in Vision and Ophthalmology titled 'Effectiveness of a hybrid telemedicine model in glaucoma management' revealed that approximately 95% of hybrid telemedicine visits resulted in findings and management plans consistent with in-person visits, underscoring the reliability driving the adoption of remote diagnostic services.

Key Market Players

  • Carl Zeiss Meditec AG
  • Topcon Corp
  • Heidelberg Engineering GmbH
  • Sonomed Escalon
  • Visbion Ltd
  • Eyepacs LLC
  • VersaSuite
  • Merge Healthcare Inc
  • ScImage Inc

Report Scope

In this report, the Global Ophthalmology PACS Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ophthalmology PACS Market, By Type

  • Standalone PACS
  • Integrated PACS

Ophthalmology PACS Market, By Mode of Action

  • On-premise system
  • Cloud-based system

Ophthalmology PACS Market, By End-use

  • Hospitals
  • Specialty clinics
  • Others

Ophthalmology PACS Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ophthalmology PACS Market.

Available Customizations:

Global Ophthalmology PACS Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ophthalmology PACS Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Standalone PACS, Integrated PACS)
    • 5.2.2. By Mode of Action (On-premise system, Cloud-based system)
    • 5.2.3. By End-use (Hospitals, Specialty clinics, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Ophthalmology PACS Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Mode of Action
    • 6.2.3. By End-use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ophthalmology PACS Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Mode of Action
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada Ophthalmology PACS Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Mode of Action
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico Ophthalmology PACS Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Mode of Action
        • 6.3.3.2.3. By End-use

7. Europe Ophthalmology PACS Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Mode of Action
    • 7.2.3. By End-use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ophthalmology PACS Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Mode of Action
        • 7.3.1.2.3. By End-use
    • 7.3.2. France Ophthalmology PACS Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Mode of Action
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom Ophthalmology PACS Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Mode of Action
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy Ophthalmology PACS Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Mode of Action
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain Ophthalmology PACS Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Mode of Action
        • 7.3.5.2.3. By End-use

8. Asia Pacific Ophthalmology PACS Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Mode of Action
    • 8.2.3. By End-use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ophthalmology PACS Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Mode of Action
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Ophthalmology PACS Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Mode of Action
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Ophthalmology PACS Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Mode of Action
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Ophthalmology PACS Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Mode of Action
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Ophthalmology PACS Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Mode of Action
        • 8.3.5.2.3. By End-use

9. Middle East & Africa Ophthalmology PACS Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Mode of Action
    • 9.2.3. By End-use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ophthalmology PACS Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Mode of Action
        • 9.3.1.2.3. By End-use
    • 9.3.2. UAE Ophthalmology PACS Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Mode of Action
        • 9.3.2.2.3. By End-use
    • 9.3.3. South Africa Ophthalmology PACS Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Mode of Action
        • 9.3.3.2.3. By End-use

10. South America Ophthalmology PACS Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Mode of Action
    • 10.2.3. By End-use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ophthalmology PACS Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Mode of Action
        • 10.3.1.2.3. By End-use
    • 10.3.2. Colombia Ophthalmology PACS Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Mode of Action
        • 10.3.2.2.3. By End-use
    • 10.3.3. Argentina Ophthalmology PACS Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Mode of Action
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ophthalmology PACS Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Carl Zeiss Meditec AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Topcon Corp
  • 15.3. Heidelberg Engineering GmbH
  • 15.4. Sonomed Escalon
  • 15.5. Visbion Ltd
  • 15.6. Eyepacs LLC
  • 15.7. VersaSuite
  • 15.8. Merge Healthcare Inc
  • 15.9. ScImage Inc

16. Strategic Recommendations

17. About Us & Disclaimer